Adrian RH, Chandler WK, Hodgkin AL. (1970). Voltage clamp experiments in striated muscle fibres. The Journal of physiology. 208 [PubMed]
Bensimon G, Lacomblez L, Meininger V. (1994). A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. The New England journal of medicine. 330 [PubMed]
Bingham JP, Bian S, Tan ZY, Takacs Z, Moczydlowski E. (2006). Synthesis of a biotin derivative of iberiotoxin: binding interactions with streptavidin and the BK Ca2+-activated K+ channel expressed in a human cell line. Bioconjugate chemistry. 17 [PubMed]
Boixel C, Gavillet B, Rougier JS, Abriel H. (2006). Aldosterone increases voltage-gated sodium current in ventricular myocytes. American journal of physiology. Heart and circulatory physiology. 290 [PubMed]
Cheung YK, Gordon PH, Levin B. (2006). Selecting promising ALS therapies in clinical trials. Neurology. 67 [PubMed]
Couratier P, Sindou P, Esclaire F, Louvel E, Hugon J. (1994). Neuroprotective effects of riluzole in ALS CSF toxicity. Neuroreport. 5 [PubMed]
Danilov AF, Gmiro VE, Fedorov DJ. (1994). In search of new neuromuscular blocking drugs with quick onset and short duration of effect. European journal of pharmacology. 257 [PubMed]
De Sarro G, Siniscalchi A, Ferreri G, Gallelli L, De Sarro A. (2000). NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice. European journal of pharmacology. 408 [PubMed]
Doble A. (1996). The pharmacology and mechanism of action of riluzole. Neurology. 47 [PubMed]
Donahue LM et al. (2000). The cardiac sodium channel mRNA is expressed in the developing and adult rat and human brain. Brain research. 887 [PubMed]
Grunnet M et al. (2001). Pharmacological modulation of SK3 channels. Neuropharmacology. 40 [PubMed]
Gurney ME, Fleck TJ, Himes CS, Hall ED. (1998). Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis. Neurology. 50 [PubMed]
Hebert T, Drapeau P, Pradier L, Dunn RJ. (1994). Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole. Molecular pharmacology. 45 [PubMed]
Kallen RG et al. (1990). Primary structure and expression of a sodium channel characteristic of denervated and immature rat skeletal muscle. Neuron. 4 [PubMed]
Keener JP, Keizer JE. (2002). Fast and slow time scales (Chapter 4) Computational Cell Biology.
Kennel P et al. (2000). Riluzole prolongs survival and delays muscle strength deterioration in mice with progressive motor neuronopathy (pmn). Journal of the neurological sciences. 180 [PubMed]
Kobayashi H et al. (2002). Regulation of voltage-dependent sodium channel expression in adrenal chromaffin cells: involvement of multiple calcium signaling pathways. Annals of the New York Academy of Sciences. 971 [PubMed]
Lu L. (1997). Effect of substituting amino acids in extracellular disulfide loop on GABA rho1 subunit function. Brain research. 756 [PubMed]
Martin D, Thompson MA, Nadler JV. (1993). The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. European journal of pharmacology. 250 [PubMed]
Mercuri NB, Bonci A, Bernardi G, Siniscalchi A. (1997). Effects of riluzole on rat cortical neurones: an in vitro electrophysiological study. Br J Pharmacol. 120
Miller RG, Mitchell JD, Lyon M, Moore DH. (2003). Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases. 4 [PubMed]
Moczydlowski E, Latorre R. (1983). Gating kinetics of Ca2+-activated K+ channels from rat muscle incorporated into planar lipid bilayers. Evidence for two voltage-dependent Ca2+ binding reactions. The Journal of general physiology. 82 [PubMed]
Mohammadi B, Lang N, Dengler R, Bufler J. (2002). Interaction of high concentrations of riluzole with recombinant skeletal muscle sodium channels and adult-type nicotinic receptor channels. Muscle & nerve. 26 [PubMed]
Ménard C et al. (1999). Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. The Journal of biological chemistry. 274 [PubMed]
Nimigean CM, Magleby KL. (1999). The beta subunit increases the Ca2+ sensitivity of large conductance Ca2+-activated potassium channels by retaining the gating in the bursting states. The Journal of general physiology. 113 [PubMed]
Peluffo H, Estevez A, Barbeito L, Stutzmann JM. (1997). Riluzole promotes survival of rat motoneurons in vitro by stimulating trophic activity produced by spinal astrocyte monolayers. Neuroscience letters. 228 [PubMed]
Rothstein JD, Kuncl RW. (1995). Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem. 65
Salkoff L, Butler A, Ferreira G, Santi C, Wei A. (2006). High-conductance potassium channels of the SLO family. Nature reviews. Neuroscience. 7 [PubMed]
Shang LL, Dudley SC. (2005). Tandem promoters and developmentally regulated 5'- and 3'-mRNA untranslated regions of the mouse Scn5a cardiac sodium channel. The Journal of biological chemistry. 280 [PubMed]
Song JH, Huang CS, Nagata K, Yeh JZ, Narahashi T. (1997). Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels. The Journal of pharmacology and experimental therapeutics. 282 [PubMed]
Taniguchi T et al. (1999). Expression of p21(Cip1/Waf1/Sdi1) and p27(Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis. Blood. 93 [PubMed]
Tricarico D, Mele A, Conte Camerino D. (2005). Phenotype-dependent functional and pharmacological properties of BK channels in skeletal muscle: effects of microgravity. Neurobiology of disease. 20 [PubMed]
Wang Q, Li Z, Shen J, Keating MT. (1996). Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics. 34 [PubMed]
Wang W, Watanabe M, Nakamura T, Kudo Y, Ochi R. (1999). Properties and expression of Ca2+-activated K+ channels in H9c2 cells derived from rat ventricle. The American journal of physiology. 276 [PubMed]
Wang YJ, Liu YC, Chang HD, Wu SN. (2006). Diosgenin, a plant-derived sapogenin, stimulates Ca2+-activated K+ current in human cortical HCN-1A neuronal cells. Planta medica. 72 [PubMed]
Wu SN, Li HF. (1999). Characterization of riluzole-induced stimulation of large-conductance calcium-activated potassium channels in rat pituitary GH3 cells. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 47 [PubMed]
Wu SN, Wang YJ, Lin MW. (2007). Potent stimulation of large-conductance Ca2+-activated K+ channels by rottlerin, an inhibitor of protein kinase C-delta, in pituitary tumor (GH3) cells and in cortical neuronal (HCN-1A) cells. Journal of cellular physiology. 210 [PubMed]
Wu SN, Wu AZ, Lin MW. (2006). Pharmacological roles of the large-conductance calcium-activated potassium channel. Current topics in medicinal chemistry. 6 [PubMed]
Yokoo H et al. (1998). Selective inhibition by riluzole of voltage-dependent sodium channels and catecholamine secretion in adrenal chromaffin cells. Naunyn-Schmiedeberg's archives of pharmacology. 357 [PubMed]
Zona C, Siniscalchi A, Mercuri NB, Bernardi G. (1998). Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons. Neuroscience. 85 [PubMed]
Chen BS, Lo YC, Lius YC, Wu SN. (2010). Effects of transient receptor potential-like current on the firing pattern of action potentials in the Hodgkin-Huxley neuron during exposure to sinusoidal external voltage. The Chinese journal of physiology. 53 [PubMed]